The positive allosteric modulator of α7 nicotinic acetylcholine receptors, 3-furan-2-yl-N-p-tolyl-acrylamide, enhances memory processes and stimulates ERK1/2 phosphorylation in mice

Katarzyna M. Targowska-Duda, Artur Wnorowski, Barbara Budzynska, Krzysztof Jozwiak, Grazyna Biala, Hugo R. Arias

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

To determine whether 3-furan-2-yl-. N-. p-tolyl-acrylamide (PAM-2), a positive allosteric modulator of α7 nicotinic acetylcholine receptors (nAChRs), improves memory processes, passive avoidance tests were conducted in male mice after acute and chronic treatments. To determine the neuronal mechanisms underlying the promnesic activity elicited by PAM-2, the effect of this ligand on α7 nAChR up-regulation and ERK1/2 phosphorylation was assessed in the hippocampus and prefrontal cortex. The results indicate that: (1) PAM-2 improves memory acquisition/consolidation after acute treatment (Day 2) and memory consolidation after chronic treatment (Day 22). Although no effect was observed on α7 nAChR up-regulation, the chronic, but not acute, PAM-2 treatment increases ERK1/2 kinase phosphorylation, (2) the promnesic activity of PAM-2 was inhibited by methyllycaconitine, a selective α7-antagonist, confirming the role of α7 nAChRs, (3) a synergistic (acute) effect was observed between inactive doses of PAM-2 (0.1 mg/kg) and DMXBA (0.3 mg/kg), a selective α7-agonist, and (4) PAM-2 reversed the memory impairment elicited by scopolamine, a muscarinic antagonist. The results demonstrate that PAM-2 presents promnesic activity mediated by α7 nAChRs, and is able to trigger ERK1/2 phosphorylation only after chronic treatment.

Original languageEnglish
Pages (from-to)142-151
Number of pages10
JournalBehavioural Brain Research
Volume302
DOIs
StatePublished - 1 Apr 2016
Externally publishedYes

Fingerprint

Acrylamide
Nicotinic Receptors
Phosphorylation
Up-Regulation
Muscarinic Antagonists
Scopolamine Hydrobromide
Mitogen-Activated Protein Kinase 3
pralidoxime
furan
Prefrontal Cortex
Hippocampus
Ligands

Keywords

  • DMXBA
  • ERK1/2 phosphorylation
  • Memory
  • Nicotine
  • Passive avoidance
  • Positive allosteric modulator
  • α7 Nicotinic acetylcholine receptor
  • α7 Up-regulation

Cite this

@article{42220c597e934c568e1f31dd790135ef,
title = "The positive allosteric modulator of α7 nicotinic acetylcholine receptors, 3-furan-2-yl-N-p-tolyl-acrylamide, enhances memory processes and stimulates ERK1/2 phosphorylation in mice",
abstract = "To determine whether 3-furan-2-yl-. N-. p-tolyl-acrylamide (PAM-2), a positive allosteric modulator of α7 nicotinic acetylcholine receptors (nAChRs), improves memory processes, passive avoidance tests were conducted in male mice after acute and chronic treatments. To determine the neuronal mechanisms underlying the promnesic activity elicited by PAM-2, the effect of this ligand on α7 nAChR up-regulation and ERK1/2 phosphorylation was assessed in the hippocampus and prefrontal cortex. The results indicate that: (1) PAM-2 improves memory acquisition/consolidation after acute treatment (Day 2) and memory consolidation after chronic treatment (Day 22). Although no effect was observed on α7 nAChR up-regulation, the chronic, but not acute, PAM-2 treatment increases ERK1/2 kinase phosphorylation, (2) the promnesic activity of PAM-2 was inhibited by methyllycaconitine, a selective α7-antagonist, confirming the role of α7 nAChRs, (3) a synergistic (acute) effect was observed between inactive doses of PAM-2 (0.1 mg/kg) and DMXBA (0.3 mg/kg), a selective α7-agonist, and (4) PAM-2 reversed the memory impairment elicited by scopolamine, a muscarinic antagonist. The results demonstrate that PAM-2 presents promnesic activity mediated by α7 nAChRs, and is able to trigger ERK1/2 phosphorylation only after chronic treatment.",
keywords = "DMXBA, ERK1/2 phosphorylation, Memory, Nicotine, Passive avoidance, Positive allosteric modulator, α7 Nicotinic acetylcholine receptor, α7 Up-regulation",
author = "Targowska-Duda, {Katarzyna M.} and Artur Wnorowski and Barbara Budzynska and Krzysztof Jozwiak and Grazyna Biala and Arias, {Hugo R.}",
year = "2016",
month = "4",
day = "1",
doi = "10.1016/j.bbr.2016.01.002",
language = "English",
volume = "302",
pages = "142--151",
journal = "Behavioural Brain Research",
issn = "0166-4328",
publisher = "Elsevier",

}

The positive allosteric modulator of α7 nicotinic acetylcholine receptors, 3-furan-2-yl-N-p-tolyl-acrylamide, enhances memory processes and stimulates ERK1/2 phosphorylation in mice. / Targowska-Duda, Katarzyna M.; Wnorowski, Artur; Budzynska, Barbara; Jozwiak, Krzysztof; Biala, Grazyna; Arias, Hugo R.

In: Behavioural Brain Research, Vol. 302, 01.04.2016, p. 142-151.

Research output: Contribution to journalArticle

TY - JOUR

T1 - The positive allosteric modulator of α7 nicotinic acetylcholine receptors, 3-furan-2-yl-N-p-tolyl-acrylamide, enhances memory processes and stimulates ERK1/2 phosphorylation in mice

AU - Targowska-Duda, Katarzyna M.

AU - Wnorowski, Artur

AU - Budzynska, Barbara

AU - Jozwiak, Krzysztof

AU - Biala, Grazyna

AU - Arias, Hugo R.

PY - 2016/4/1

Y1 - 2016/4/1

N2 - To determine whether 3-furan-2-yl-. N-. p-tolyl-acrylamide (PAM-2), a positive allosteric modulator of α7 nicotinic acetylcholine receptors (nAChRs), improves memory processes, passive avoidance tests were conducted in male mice after acute and chronic treatments. To determine the neuronal mechanisms underlying the promnesic activity elicited by PAM-2, the effect of this ligand on α7 nAChR up-regulation and ERK1/2 phosphorylation was assessed in the hippocampus and prefrontal cortex. The results indicate that: (1) PAM-2 improves memory acquisition/consolidation after acute treatment (Day 2) and memory consolidation after chronic treatment (Day 22). Although no effect was observed on α7 nAChR up-regulation, the chronic, but not acute, PAM-2 treatment increases ERK1/2 kinase phosphorylation, (2) the promnesic activity of PAM-2 was inhibited by methyllycaconitine, a selective α7-antagonist, confirming the role of α7 nAChRs, (3) a synergistic (acute) effect was observed between inactive doses of PAM-2 (0.1 mg/kg) and DMXBA (0.3 mg/kg), a selective α7-agonist, and (4) PAM-2 reversed the memory impairment elicited by scopolamine, a muscarinic antagonist. The results demonstrate that PAM-2 presents promnesic activity mediated by α7 nAChRs, and is able to trigger ERK1/2 phosphorylation only after chronic treatment.

AB - To determine whether 3-furan-2-yl-. N-. p-tolyl-acrylamide (PAM-2), a positive allosteric modulator of α7 nicotinic acetylcholine receptors (nAChRs), improves memory processes, passive avoidance tests were conducted in male mice after acute and chronic treatments. To determine the neuronal mechanisms underlying the promnesic activity elicited by PAM-2, the effect of this ligand on α7 nAChR up-regulation and ERK1/2 phosphorylation was assessed in the hippocampus and prefrontal cortex. The results indicate that: (1) PAM-2 improves memory acquisition/consolidation after acute treatment (Day 2) and memory consolidation after chronic treatment (Day 22). Although no effect was observed on α7 nAChR up-regulation, the chronic, but not acute, PAM-2 treatment increases ERK1/2 kinase phosphorylation, (2) the promnesic activity of PAM-2 was inhibited by methyllycaconitine, a selective α7-antagonist, confirming the role of α7 nAChRs, (3) a synergistic (acute) effect was observed between inactive doses of PAM-2 (0.1 mg/kg) and DMXBA (0.3 mg/kg), a selective α7-agonist, and (4) PAM-2 reversed the memory impairment elicited by scopolamine, a muscarinic antagonist. The results demonstrate that PAM-2 presents promnesic activity mediated by α7 nAChRs, and is able to trigger ERK1/2 phosphorylation only after chronic treatment.

KW - DMXBA

KW - ERK1/2 phosphorylation

KW - Memory

KW - Nicotine

KW - Passive avoidance

KW - Positive allosteric modulator

KW - α7 Nicotinic acetylcholine receptor

KW - α7 Up-regulation

UR - http://www.scopus.com/inward/record.url?scp=84955490492&partnerID=8YFLogxK

U2 - 10.1016/j.bbr.2016.01.002

DO - 10.1016/j.bbr.2016.01.002

M3 - Article

C2 - 26778787

AN - SCOPUS:84955490492

VL - 302

SP - 142

EP - 151

JO - Behavioural Brain Research

JF - Behavioural Brain Research

SN - 0166-4328

ER -